💪 12 key compounds

Growth Hormone Peptides

Growth hormone peptides encompass a diverse group of secretagogues that stimulate the pituitary gland to produce and release growth hormone (GH). They are among the most extensively researched peptide classes in endocrinology and anti-aging science.

GHRPsGHRHsSecretagoguesIGF-1Pituitary
12
Key compounds documented
1980s
First GHRPs discovered
Pituitary
Primary target organ
GH/IGF-1
Key hormones involved

Overview

Growth hormone (GH) peptides work by stimulating the pituitary gland to increase the secretion of endogenous growth hormone. Unlike direct GH administration, these peptides preserve the natural pulsatile release pattern of GH, which is considered more physiologically appropriate.

The two main subcategories are Growth Hormone Releasing Peptides (GHRPs), which act on the ghrelin receptor, and Growth Hormone Releasing Hormone analogues (GHRHs), which act on the GHRH receptor. These two classes can work synergistically when combined.

Research has demonstrated that GH peptides may support muscle anabolism, fat metabolism, bone density, sleep quality, and various repair processes through their effects on the GH/IGF-1 axis.

Key Compounds

Ipamorelin

GHRP

Highly selective GH secretagogue with minimal effect on cortisol and prolactin. Considered one of the cleanest GHRPs in research.

GH releaseSelectiveMild side effects

CJC-1295

GHRH

Long-acting GHRH analogue that extends the half-life of endogenous GHRH. Available with or without DAC (Drug Affinity Complex).

Sustained GHIGF-1 increaseLong-acting

GHRP-2

GHRP

Potent GH secretagogue that significantly increases GH pulse amplitude. Studied for performance and anti-aging research.

Strong GH pulseIGF-1Appetite

GHRP-6

GHRP

One of the first discovered GHRPs. Strong hunger-stimulating properties alongside GH release, studied in eating disorder research.

GH releaseAppetite increaseCortisol

Sermorelin

GHRH

A 29-amino acid analogue of GHRH, used in clinical research for GH deficiency. One of the most studied GHRH analogues.

GH stimulationNatural patternWell-studied

Tesamorelin

GHRH

FDA-approved GHRH analogue for HIV-associated lipodystrophy. Extensively studied for visceral fat reduction.

Visceral fatMetabolicFDA approved

Mechanism of Action

1

Receptor Binding

GHRPs bind to the ghrelin/GHS receptor (GHSR) in the pituitary and hypothalamus, while GHRHs bind to the GHRH receptor on pituitary somatotrophs.

2

Signal Transduction

Receptor activation triggers intracellular signaling cascades including cAMP elevation and IP3/DAG pathways, leading to calcium influx.

3

GH Secretion

The signaling cascade stimulates synthesis and pulsatile release of growth hormone from pituitary somatotroph cells into circulation.

4

IGF-1 Production

Elevated circulating GH stimulates the liver to produce Insulin-like Growth Factor 1 (IGF-1), mediating many anabolic and metabolic effects.

Research Applications

🏋️

Muscle Research

Studying the effects of GH/IGF-1 axis activation on protein synthesis and lean mass.

🧬

Anti-Aging Science

Investigating how GH optimization may slow age-related decline in body composition and function.

😴

Sleep Studies

GH release is linked to slow-wave sleep; research explores bidirectional relationships.

⚖️

Metabolic Research

Examining effects on fat metabolism, insulin sensitivity, and energy expenditure.

Frequently Asked Questions

What is the difference between GHRPs and GHRHs?
GHRPs (Growth Hormone Releasing Peptides) like Ipamorelin and GHRP-2 act on the ghrelin receptor to stimulate a GH pulse. GHRHs (Growth Hormone Releasing Hormone analogues) like CJC-1295 and Sermorelin act on the GHRH receptor to amplify the natural GH wave. Combining both can produce a synergistic effect.
How does Ipamorelin differ from GHRP-2 and GHRP-6?
Ipamorelin is highly selective — it stimulates GH release without significantly raising cortisol, prolactin, or appetite. GHRP-2 is more potent but raises cortisol and prolactin. GHRP-6 strongly increases appetite alongside GH release, which can be useful in some contexts but undesirable in others.
What is MK-677 and is it a peptide?
MK-677 (Ibutamoren) is technically not a peptide — it is a non-peptide ghrelin receptor agonist that mimics the GH-releasing action of GHRPs. It is orally active, unlike most GH peptides which require injection. It stimulates GH and IGF-1 over a prolonged period.
What does IGF-1 do in the GH axis?
After GH is released from the pituitary, the liver produces Insulin-like Growth Factor 1 (IGF-1). IGF-1 mediates most of the anabolic and metabolic effects attributed to GH — protein synthesis, muscle growth, fat metabolism, and tissue repair. IGF-1 LR3 and IGF-1 DES are research variants with modified half-lives.
⚠️

Research Information Only

This content is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional before making any health-related decisions.